Last reviewed · How we verify

NCT02341833

Effects of Preconditioning With Sevoflurane During Organ Procurement From Brain Dead Donors: Impact on Early Function of Liver Allografts

Status unknown Phase 4 Last updated 20 January 2015
What this trial tests

Phase 4 trial testing Sevoflurane in Post-transplantation Liver Allograft Function in 240 participants. Status unknown.

Timeline
1 January 2015
Primary endpoint
1 December 2017

Quick facts

Lead sponsorUniversity of Liege
PhasePhase 4
StatusStatus unknown
Study typeINTERVENTIONAL
Allocationrandomized
Designparallel
Maskingquadruple
Primary purposetreatment
Enrollment240
Start date1 January 2015
Primary completion1 December 2017
Sites1 location across Belgium

Drugs / interventions tested

Conditions studied

Sponsor

University of Liege

Who can join

Eligibility, any sex, with Post-transplantation Liver Allograft Function. Patients with the condition only — healthy volunteers not accepted.

What's being measured

Primary outcomes are the specific endpoints the trial is designed to prove or disprove.

Sponsor's own description

The aim of the investigators study is to investigate the effects of anaesthetic preconditioning with sevoflurane during organs harvesting in brain dead donors. More particularly, the investigators will investigate whether sevoflurane preconditioning protects against ischaemia-reperfusion the livers and kidneys allografts after a prolonged period of cold ischaemia and whether this protection translates in a better clinical functional recovery of these allografts.

Publications & conference data

No peer-reviewed publications indexed yet for this trial.

Verify or expand the search:

Other trials of Sevoflurane

Trials testing the same drug.

Other University of Liege trials

Trials by the same sponsor.

Verify against primary sources

Data sources for this page

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT02341833.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing